Chinese Firm, CEO Plead Guilty In U.S. Human Growth Hormones Case
This article was originally published in PharmAsia News
Executive Summary
China's GeneScience Pharmaceutical and its CEO entered a guilty plea in a U.S. case involving distribution of human growth hormones